Synthetic Cellular Immunity based on CAR repertoire for Human Immunotherapy
W. Fu, Z. Ma, C. Wang, T. Li, F. Lin, R. Mao, C. Lei, J. Zhao, S. Hu
Abstract
The immune surveillance hypothesis is regarded as the intellectual underpinning of cancer immunology. We find that engineered T cell library displaying CAR constructs, where the antibody repertoires took the place of the antigen-recognition region, has the capacity to recognize nonself-antigens and showed antigen dependent clonal expanding and persistence. This process coupled with long-lasting anti-tumour effect in a broad spectrum of epithelial tumours. Moreover, CAR-T library showed robust immunologic memory and maintenance of diversity to recognize mutated or evolved tumours in both immunodeficiency and immunoresponsive murine tumor models. Large CAR library was further developed in logic-gated NK-92 cells to develop an off-the shelf therapeutic library. Thus, the biological behaviour of synthetic cell library is highly accordance with the immune surveillance function, which proved the way to rebuilt functional MHC unrestricted cellular immunity in vitro using synthetic method.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Sensitizing solid tumors to CAR-mediated cytotoxicity using synthetic antigens
L. Gamboa, A. H. Zamat, … G. A. Kwong·bioRxiv·Dec 11, 2021
- A Lymphomimetic Synthetic Immune Niche, Consisting of CCL21 and ICAM1, Accelerates the Expansion of Potent CAR T-cells
Karin Brezinger-Dayan, Sofi Yado, … Michal Judith Besser·bioRxiv·Sep 3, 2026
- Identification of human CD4+ T cell populations with distinct antitumor activity
M. H. Nelson, H. M. Knochelmann, … C. M. Paulos·bioRxiv·Dec 31, 2019
- CARs are organized in nanodomains in the plasma membrane of T cells that accumulate at tumor contact sites
C. Verbruggen, L. Gehrke, … M. Sauer·bioRxiv·Jul 19, 2023
- Engineering programmable CAR-T cells with tunable controls as fail-safe mechanisms during cancer immunotherapy
Mikail Dogan, Lina Kozhaya, … Derya Unutmaz·bioRxiv·Jul 9, 2024
- Rational protein engineering to enhance MHC-independent T cell receptors
Ju-Fang Chang, Jack H. Landmann, … Nathan Singh·Cancer DiscoveryPeer-reviewed·Jul 9, 2024